Skip to main content

Articles

March 13, 2006

Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia

N. Elleuch, MD, C. Depienne, PhD, A. Benomar, MD, A. M. Ouvrard Hernandez, MD, X. Ferrer, MD, B. Fontaine, MD, D. Grid, MD, C.M.E. Tallaksen, MD, R. Zemmouri, MD, G. Stevanin, PhD, A. Durr, MD, and A. Brice, MDAuthors Info & Affiliations

March 14, 2006 issue

66 (5) 654-659

https://doi.org/10.1212/01.wnl.0000201185.91110.15

Abstract

Background: Mutations in the SPG7 gene, which encodes paraplegin, are responsible for an autosomal recessive hereditary spastic paraplegia (HSP).

Objective: To screen the SPG7 gene in a large population of HSP families compatible with autosomal recessive transmission.

Methods: The authors analyzed 136 probands with pure or complex HSP for mutations in the SPG7 using denaturation high-performance liquid chromatography and direct sequencing.

Results: The authors identified 47 variants including 6 mutations, 27 polymorphisms, and 14 changes with unknown effects. In one family from Morocco, compound c.850_851delTTinsC and c.1742_1744delTGG heterozygous mutations were shown to be causative. This family had complex HSP with cerebellar impairment. Progression of the disease was rapid, resulting in a severe disease after 8 years of duration. Also detected were 20 families with one heterozygous mutation that was not found in a large control population. The mutations produced highly defective proteins in four of these families, suggesting that they were probably causative. Direct sequencing of all exons and reverse transcription PCR experiments demonstrated the absence of a second mutation. However, the p.Ala510Val missense substitution previously described as a polymorphism was shown to be significantly associated with HSP, suggesting that it had a functional effect.

Conclusion: SPG7 mutations account for less than 5% of hereditary spastic paraplegia (HSP) families compatible with autosomal recessive inheritance. Cerebellar signs or cerebellar atrophy on brain imaging were the most frequent additional features in patients with SPG7 HSP. Rare nucleotide variants in SPG7 are frequent, complicating routine diagnosis.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (e1.doc)

Download
71.00 KB

File (e2.doc)

Download
41.50 KB

References

1.

Fink JK. Advances in hereditary spastic paraplegia. Curr Opin Neurol 1997;10:313–318.

2.

Deluca GC, Ebers GC, Esiri MM. The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol 2004;30:576–584.

3.

Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet 1983;1:1151–1155.

4.

Fink JK, Heiman-Patterson T, Bird T, et al. Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working Group. Neurology 1996;46:1507–1514.

5.

De Michele G, De Fusco M, Cavalcanti F, et al. A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. Am J Hum Genet 1998;63:135–139.

6.

Casari G, De Fusco M, Ciarmatori S, et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998;93:973–983.

7.

Wilkinson PA, Crosby AH, Turner C, et al. A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. Brain 2004;127:973–980.

8.

Settasatian C, Whitmore SA, Crawford J, et al. Genomic structure and expression analysis of the spastic paraplegia gene, SPG7. Hum Genet 1999;105:139–144.

9.

Patel S, Latterich M. The AAA team: related ATPases with diverse functions. Trends Cell Biol 1998;8:65–71.

10.

Atorino L, Silvestri L, Koppen M, et al. Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol 2003;163:777–787.

11.

Nolden M, Ehses S, Koppen M, Bernacchia A, Rugarli EI, Langer T. The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. Cell 2005;123:277–289.

12.

Claypool SM, Koehler CM. Hereditary spastic paraplegia: respiratory choke or unactivated substrate? Cell 2005;123:183–185.

13.

McDermott CJ, Dayaratne RK, Tomkins J, et al. Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England. Neurology 2001;56:467–471.

14.

Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002;30:3894–3900.

15.

Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 2003;31:3812–3814.

16.

Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: a Web resource to identify exonic splicing enhancers. Nucleic Acids Res 2003;31:3568–3571.

Information & Authors

Information

Published In

Neurology^®

Volume 66 • Number 5 • March 14, 2006

Pages: 654-659

PubMed: 16534102

Copyright

© 2006.

Publication History

Published online: March 13, 2006

Published in issue: March 14, 2006

Permissions

Request permissions for this article.

Request Permissions

Authors

Affiliations & Disclosures

N. Elleuch, MD

From INSERM U679, Neurology and Experimental Therapeutics, Département de Génétique, Cytogénétique, et Embryologie, Hôpital de la Pitié-Salpêtrière, and Université Pierre et Marie Curie, Faculté de Médecine, Paris (N.E., C.D., C.M.E.T., G.S., A.D., A.B.), Department of Neurology (A.M.O.H.), Centre Hospitalier Universitaire, Grenoble, Department of Neurology (X.F.), Centre Hospitalier Universitaire, Bordeaux, INSERM U546 (B.F.), Hôpital de la Pitié-Salpêtrière, Paris, and Généthon III (D.G.), Evry, France; Laboratory of Neurogenetics and Department of Neurology (A.B.), Hôpital des Spécialités, Rabat, Morocco; and Department of Neurology (R.Z.), Centre Hospitalier Universitaire Mustapha Bacha, Alger, Algeria.

View all articles by this author

C. Depienne, PhD

From INSERM U679, Neurology and Experimental Therapeutics, Département de Génétique, Cytogénétique, et Embryologie, Hôpital de la Pitié-Salpêtrière, and Université Pierre et Marie Curie, Faculté de Médecine, Paris (N.E., C.D., C.M.E.T., G.S., A.D., A.B.), Department of Neurology (A.M.O.H.), Centre Hospitalier Universitaire, Grenoble, Department of Neurology (X.F.), Centre Hospitalier Universitaire, Bordeaux, INSERM U546 (B.F.), Hôpital de la Pitié-Salpêtrière, Paris, and Généthon III (D.G.), Evry, France; Laboratory of Neurogenetics and Department of Neurology (A.B.), Hôpital des Spécialités, Rabat, Morocco; and Department of Neurology (R.Z.), Centre Hospitalier Universitaire Mustapha Bacha, Alger, Algeria.

View all articles by this author

A. Benomar, MD

From INSERM U679, Neurology and Experimental Therapeutics, Département de Génétique, Cytogénétique, et Embryologie, Hôpital de la Pitié-Salpêtrière, and Université Pierre et Marie Curie, Faculté de Médecine, Paris (N.E., C.D., C.M.E.T., G.S., A.D., A.B.), Department of Neurology (A.M.O.H.), Centre Hospitalier Universitaire, Grenoble, Department of Neurology (X.F.), Centre Hospitalier Universitaire, Bordeaux, INSERM U546 (B.F.), Hôpital de la Pitié-Salpêtrière, Paris, and Généthon III (D.G.), Evry, France; Laboratory of Neurogenetics and Department of Neurology (A.B.), Hôpital des Spécialités, Rabat, Morocco; and Department of Neurology (R.Z.), Centre Hospitalier Universitaire Mustapha Bacha, Alger, Algeria.

View all articles by this author

A. M. Ouvrard Hernandez, MD

From INSERM U679, Neurology and Experimental Therapeutics, Département de Génétique, Cytogénétique, et Embryologie, Hôpital de la Pitié-Salpêtrière, and Université Pierre et Marie Curie, Faculté de Médecine, Paris (N.E., C.D., C.M.E.T., G.S., A.D., A.B.), Department of Neurology (A.M.O.H.), Centre Hospitalier Universitaire, Grenoble, Department of Neurology (X.F.), Centre Hospitalier Universitaire, Bordeaux, INSERM U546 (B.F.), Hôpital de la Pitié-Salpêtrière, Paris, and Généthon III (D.G.), Evry, France; Laboratory of Neurogenetics and Department of Neurology (A.B.), Hôpital des Spécialités, Rabat, Morocco; and Department of Neurology (R.Z.), Centre Hospitalier Universitaire Mustapha Bacha, Alger, Algeria.

View all articles by this author

X. Ferrer, MD

From INSERM U679, Neurology and Experimental Therapeutics, Département de Génétique, Cytogénétique, et Embryologie, Hôpital de la Pitié-Salpêtrière, and Université Pierre et Marie Curie, Faculté de Médecine, Paris (N.E., C.D., C.M.E.T., G.S., A.D., A.B.), Department of Neurology (A.M.O.H.), Centre Hospitalier Universitaire, Grenoble, Department of Neurology (X.F.), Centre Hospitalier Universitaire, Bordeaux, INSERM U546 (B.F.), Hôpital de la Pitié-Salpêtrière, Paris, and Généthon III (D.G.), Evry, France; Laboratory of Neurogenetics and Department of Neurology (A.B.), Hôpital des Spécialités, Rabat, Morocco; and Department of Neurology (R.Z.), Centre Hospitalier Universitaire Mustapha Bacha, Alger, Algeria.

View all articles by this author

B. Fontaine, MD

From INSERM U679, Neurology and Experimental Therapeutics, Département de Génétique, Cytogénétique, et Embryologie, Hôpital de la Pitié-Salpêtrière, and Université Pierre et Marie Curie, Faculté de Médecine, Paris (N.E., C.D., C.M.E.T., G.S., A.D., A.B.), Department of Neurology (A.M.O.H.), Centre Hospitalier Universitaire, Grenoble, Department of Neurology (X.F.), Centre Hospitalier Universitaire, Bordeaux, INSERM U546 (B.F.), Hôpital de la Pitié-Salpêtrière, Paris, and Généthon III (D.G.), Evry, France; Laboratory of Neurogenetics and Department of Neurology (A.B.), Hôpital des Spécialités, Rabat, Morocco; and Department of Neurology (R.Z.), Centre Hospitalier Universitaire Mustapha Bacha, Alger, Algeria.

View all articles by this author

D. Grid, MD

From INSERM U679, Neurology and Experimental Therapeutics, Département de Génétique, Cytogénétique, et Embryologie, Hôpital de la Pitié-Salpêtrière, and Université Pierre et Marie Curie, Faculté de Médecine, Paris (N.E., C.D., C.M.E.T., G.S., A.D., A.B.), Department of Neurology (A.M.O.H.), Centre Hospitalier Universitaire, Grenoble, Department of Neurology (X.F.), Centre Hospitalier Universitaire, Bordeaux, INSERM U546 (B.F.), Hôpital de la Pitié-Salpêtrière, Paris, and Généthon III (D.G.), Evry, France; Laboratory of Neurogenetics and Department of Neurology (A.B.), Hôpital des Spécialités, Rabat, Morocco; and Department of Neurology (R.Z.), Centre Hospitalier Universitaire Mustapha Bacha, Alger, Algeria.

View all articles by this author

C.M.E. Tallaksen, MD

From INSERM U679, Neurology and Experimental Therapeutics, Département de Génétique, Cytogénétique, et Embryologie, Hôpital de la Pitié-Salpêtrière, and Université Pierre et Marie Curie, Faculté de Médecine, Paris (N.E., C.D., C.M.E.T., G.S., A.D., A.B.), Department of Neurology (A.M.O.H.), Centre Hospitalier Universitaire, Grenoble, Department of Neurology (X.F.), Centre Hospitalier Universitaire, Bordeaux, INSERM U546 (B.F.), Hôpital de la Pitié-Salpêtrière, Paris, and Généthon III (D.G.), Evry, France; Laboratory of Neurogenetics and Department of Neurology (A.B.), Hôpital des Spécialités, Rabat, Morocco; and Department of Neurology (R.Z.), Centre Hospitalier Universitaire Mustapha Bacha, Alger, Algeria.

View all articles by this author

R. Zemmouri, MD

From INSERM U679, Neurology and Experimental Therapeutics, Département de Génétique, Cytogénétique, et Embryologie, Hôpital de la Pitié-Salpêtrière, and Université Pierre et Marie Curie, Faculté de Médecine, Paris (N.E., C.D., C.M.E.T., G.S., A.D., A.B.), Department of Neurology (A.M.O.H.), Centre Hospitalier Universitaire, Grenoble, Department of Neurology (X.F.), Centre Hospitalier Universitaire, Bordeaux, INSERM U546 (B.F.), Hôpital de la Pitié-Salpêtrière, Paris, and Généthon III (D.G.), Evry, France; Laboratory of Neurogenetics and Department of Neurology (A.B.), Hôpital des Spécialités, Rabat, Morocco; and Department of Neurology (R.Z.), Centre Hospitalier Universitaire Mustapha Bacha, Alger, Algeria.

View all articles by this author

G. Stevanin, PhD

From INSERM U679, Neurology and Experimental Therapeutics, Département de Génétique, Cytogénétique, et Embryologie, Hôpital de la Pitié-Salpêtrière, and Université Pierre et Marie Curie, Faculté de Médecine, Paris (N.E., C.D., C.M.E.T., G.S., A.D., A.B.), Department of Neurology (A.M.O.H.), Centre Hospitalier Universitaire, Grenoble, Department of Neurology (X.F.), Centre Hospitalier Universitaire, Bordeaux, INSERM U546 (B.F.), Hôpital de la Pitié-Salpêtrière, Paris, and Généthon III (D.G.), Evry, France; Laboratory of Neurogenetics and Department of Neurology (A.B.), Hôpital des Spécialités, Rabat, Morocco; and Department of Neurology (R.Z.), Centre Hospitalier Universitaire Mustapha Bacha, Alger, Algeria.

View all articles by this author

A. Durr, MD

From INSERM U679, Neurology and Experimental Therapeutics, Département de Génétique, Cytogénétique, et Embryologie, Hôpital de la Pitié-Salpêtrière, and Université Pierre et Marie Curie, Faculté de Médecine, Paris (N.E., C.D., C.M.E.T., G.S., A.D., A.B.), Department of Neurology (A.M.O.H.), Centre Hospitalier Universitaire, Grenoble, Department of Neurology (X.F.), Centre Hospitalier Universitaire, Bordeaux, INSERM U546 (B.F.), Hôpital de la Pitié-Salpêtrière, Paris, and Généthon III (D.G.), Evry, France; Laboratory of Neurogenetics and Department of Neurology (A.B.), Hôpital des Spécialités, Rabat, Morocco; and Department of Neurology (R.Z.), Centre Hospitalier Universitaire Mustapha Bacha, Alger, Algeria.

View all articles by this author

A. Brice, MD

From INSERM U679, Neurology and Experimental Therapeutics, Département de Génétique, Cytogénétique, et Embryologie, Hôpital de la Pitié-Salpêtrière, and Université Pierre et Marie Curie, Faculté de Médecine, Paris (N.E., C.D., C.M.E.T., G.S., A.D., A.B.), Department of Neurology (A.M.O.H.), Centre Hospitalier Universitaire, Grenoble, Department of Neurology (X.F.), Centre Hospitalier Universitaire, Bordeaux, INSERM U546 (B.F.), Hôpital de la Pitié-Salpêtrière, Paris, and Généthon III (D.G.), Evry, France; Laboratory of Neurogenetics and Department of Neurology (A.B.), Hôpital des Spécialités, Rabat, Morocco; and Department of Neurology (R.Z.), Centre Hospitalier Universitaire Mustapha Bacha, Alger, Algeria.

View all articles by this author

Notes

Address correspondence and reprint requests to Dr. A. Brice, INSERM U679, Groupe Hospitalier Pitié-Salpêtrière, 47 boulevard de l’hôpital, 75013 Paris, France; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By

- Mehri Salari,
- Fatemeh Hojjatipour,
- Masoud Etemadifar,
- Sevim Soleimani,
Review of the Genetic Spectrum of Hereditary Spastic Paraplegias in the Middle East and North Africa Regions, Neurology Genetics, 11, 2, (2025)./doi/10.1212/NXG.0000000000200250
Abstract
- Carter A. Bell,
- Melissa W. Ko,
- Devin D. Mackay,
- Lulu L. C. D. Bursztyn,
- Scott N. Grossman,
Spastic Paraplegia Type 7-Associated Optic Neuropathy: A Case Series, Journal of Neuro-Ophthalmology, (2023).https://doi.org/10.1097/WNO.0000000000002039
Crossref
- Anya Hadji,
- Aurélie Louit,
- Vincent Roy,
- Mathieu Blais,
- François Berthod,
- François Gros-Louis,
- Nicolas Dupré,
Autosomal and X-Linked Degenerative Ataxias: From Genetics to Promising Therapeutics, Trials for Cerebellar Ataxias, (141-181), (2023).https://doi.org/10.1007/978-3-031-24345-5_5
Crossref
- Gorka Fernández-Eulate,
- Aurora Pujol,
- Adolfo López de Munain,
Spastic Paraplegia Type 7 (SPG7), Essentials of Cerebellum and Cerebellar Disorders, (691-695), (2023).https://doi.org/10.1007/978-3-031-15070-8_104
Crossref
- Yuri Seo,
- Hyun Taek Lim,
- Byung Joo Lee,
- Jinu Han,
Expanding SPG7 dominant optic atrophy phenotype: Infantile nystagmus and optic atrophy without spastic paraplegia , American Journal of Medical Genetics Part A, 191, 2, (582-585), (2022).https://doi.org/10.1002/ajmg.a.63037
Crossref
- Kathrine O. Eriksen,
- Andreas Reidar Wigers,
- Iselin Marie Wedding,
- Anne Kjersti Erichsen,
- Tuva Barøy,
- Kristoffer Søberg,
- Øystein Kalsnes Jørstad,
A novel homozygous variant in the SPG7 gene presenting with childhood optic nerve atrophy, American Journal of Ophthalmology Case Reports, 26, (101400), (2022).https://doi.org/10.1016/j.ajoc.2022.101400
Crossref
- Fu Xing,
- Juan Du,
Expansion of the mutation and phenotypic spectrum of hereditary spastic paraplegia, Neurological Sciences, 43, 8, (4989-4996), (2022).https://doi.org/10.1007/s10072-022-05921-3
Crossref
- Amokelani C. Mahungu,
- Nomakhosazana Monnakgotla,
- Melissa Nel,
- Jeannine M. Heckmann,
A review of the genetic spectrum of hereditary spastic paraplegias, inherited neuropathies and spinal muscular atrophies in Africans, Orphanet Journal of Rare Diseases, 17, 1, (2022).https://doi.org/10.1186/s13023-022-02280-2
Crossref
- Selma Mekić,
- David A. Gunn,
- Leonie C. Jacobs,
- DirkJan Hijnen,
- M. Arfan Ikram,
- Andrew E. Mayes,
- Tamar Nijsten,
- Luba M. Pardo,
Genetic Susceptibility to Dry Skin in a General Middle-Aged to Elderly Population: A GWAS, Journal of Investigative Dermatology, 141, 8, (2077-2079.e5), (2021).https://doi.org/10.1016/j.jid.2020.12.033
Crossref
- James Chapman,
- Yi Shiau Ng,
- Thomas J. Nicholls,
The Maintenance of Mitochondrial DNA Integrity and Dynamics by Mitochondrial Membranes, Life, 10, 9, (164), (2020).https://doi.org/10.3390/life10090164
Crossref
See more

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login

Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
[email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

advertisement

We value your opinion!

We want to hear from you about your experience with our website. Share your feedback in a brief survey.

Open Review Pilot Project

Explore peer reviews, author responses, and editor comments on selected articles.

Learn More

Letters to the Editor

The Letters section represents an opportunity for ongoing author debate and post-publication peer review. View our submission guidelines for Letters to the Editor before submitting your comment.

Submit a Letter for this article

Topics

Genetics Movement Disorders Spastic paraplegia

Impact Factor

We are pleased to announce that Neurology^® was awarded a new Impact Factor of 8.4. Explore our latest research and articles and join our community of distinguished authors by submitting your work .

View full text|Download PDF